STOCK TITAN

[Form 4] AEHR TEST SYSTEMS Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

AEHR Test Systems (AEHR) chief financial officer Chris Siu reported a withholding-related disposition of 126 shares of common stock on 10/02/2025 at a price of $32.25 per share; the filing states these shares were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and do not represent a sale by the reporting person. After the withholding, the report shows 75,409 shares beneficially owned directly and 5,211 shares beneficially owned indirectly by a trust, with the reported direct total including shares subject to unvested restricted stock units.

AEHR Test Systems (AEHR) il direttore finanziario Chris Siu ha riferito una disposizione relativa a trattenute di 126 azioni ordinarie in data 10/02/2025 al prezzo di $32.25 per azione; la dichiarazione indica che queste azioni sono state trattenute per soddisfare gli obblighi di ritenuta fiscale al vesting delle unità azionarie soggette a restrizioni e non costituiscono una vendita da parte della persona che presenta il rapporto. Dopo la trattenuta, il rapporto mostra 75.409 azioni detenute beneficiariamente direttamente e 5.211 azioni detenute beneficiariamente indirettamente da un trust, con il totale diretto riportato che include azioni soggette a restrizioni non vestite delle unità azionarie soggette a restrizioni.

AEHR Test Systems (AEHR) el director financiero Chris Siu reportó una disposición relacionada con retención de 126 acciones comunes en fecha 10/02/2025 a un precio de $32.25 por acción; el escrito indica que estas acciones fueron retenidas para satisfacer las obligaciones de retención de impuestos al vesting de las unidades de acciones restringidas y no representan una venta por parte de la persona que presenta el informe. Después de la retención, el informe muestra 75,409 acciones beneficiosamente poseídas directamente y 5,211 acciones poseídas indirectamente por un fideicomiso, con el total directo informado que incluye las acciones sujetas a unidades de acciones restringidas no vestidas.

AEHR Test Systems (AEHR)의 최고재무책임자 크리스 시우는 126주 일반주를 예치 관련 처분을 보고했다. 날짜는 2025-10-02이고 주당 가격은 $32.25이다; 제출 문서에는 이 주식이 가상 실권 취득 시의 세금 원천징수 의무를 충족하기 위해 보류되었으며 보고자에 의한 매도를 나타내지 않는다고 명시되어 있다. 원천징수 후 보고서는 직접적으로 유익하게 보유한 주식 75,409주와 신탁에 의해 간접적으로 보유된 5,211주를 보여주며, 보고된 직접 총계에는 vesting되지 않은 제한 주식 단위로 주식이 포함되어 있다.

AEHR Test Systems (AEHR) le directeur financier Chris Siu a signalé une cession liée à une retenue de 126 actions ordinaires le 10/02/2025 au prix de $32.25 par action ; le dépôt indique que ces actions ont été retenues pour satisfaire les obligations de retenue d'impôt lors de l'acquisition des droits sur les unités d'actions restreintes et ne constituent pas une vente par la personne déclarant. Après la retenue, le rapport indique 75 409 actions détenues directement et 5 211 actions détenues indirectement par une fiducie, le total direct rapporté incluant les actions soumises à des unités d'actions restreintes non vesties.

AEHR Test Systems (AEHR) Chief Financial Officer Chris Siu meldete eine durch Abzüge bedingte Veräußerung von 126 Stammaktien am 10/02/2025 zu einem Preis von $32.25 pro Aktie; das Filing gibt an, dass diese Aktien gehalten wurden, um Steuerrückstände bei der Vesting von Restricted Stock Units zu befriedigen, und keine Veräußerung durch den meldepflichtigen Personen darstellt. Nach dem Abzug zeigt der Bericht 75.409 Aktien, direkt beneffizial besessen sind, und 5.211 Aktien indirekt durch einen Treuhändervertrag beneffizial besitzen, wobei der direkte Gesamtbestand Aktien umfasst, die unvested Restricted Stock Units unterliegen.

AEHR Test Systems (AEHR) أبلغ المدير المالي كريس سيو عن تصرف مرتبط بالاقتطاع يتعلق بـ 126 سهماً من الأسهم العادية في تاريخ 10/02/2025 بسعر $32.25 للسهم الواحد؛ يذكر الملف أن هذه الأسهم قد تم حجزها لتلبية الالتزامات بالاقتطاع الضريبي عند استحقاق وحدات الأسهم المقيدة و لا تمثل بيعاً من قبل الشخص المبلغ عنه. بعد الاقتطاع، يظهر التقرير أن هناك 75,409 سهماً مًلكاً مستفيداً مباشرة و 5,211 سهماً مًلكاً مستفيداً بشكل غير مباشر عن طريق وصيّة، مع الإدراج المباشر المبلغ عنه الذي يشمل الأسهم الخاضعة للوحدات المقيدة غير المستحقة للاستحقاق.

AEHR Test Systems (AEHR) 的首席财务官 Chris Siu 报告了一项与预扣相关的处置,涉及在 10/02/2025 以每股 $32.25 的价格出售 126 股普通股;文件指出这部分股票是为了满足归属限制性股票单位时的税务代扣义务而被保留,并且 不代表报告人出售。扣除后,报告显示直接受益持有 75,409 股,且由信托间接受益持有 5,211 股,所报的直接总额包括未归属的受限股票单位所涉及的股票。

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Withholding of 126 shares for taxes reduced direct holdings; disclosure is routine.

The filing documents a tax-withholding disposition of 126 shares on 10/02/2025 at $32.25 per share connected to the vesting of restricted stock units. The report explicitly states this is not a sale by the reporting person, which is a common administrative step when equity awards vest.

Reported beneficial ownership after the transaction is 75,409 shares direct and 5,211 shares indirect via a trust; the direct count includes unvested restricted stock units. Monitor future Form 4s if additional vesting, withholdings, or open-market transactions are disclosed in coming quarters.

TL;DR: The movement reflects routine RSU tax withholding, not an active cash sale.

The explanation clarifies the withheld 126 shares satisfied tax obligations on vested restricted stock units, which reduces the net number of shares delivered to the officer at vesting while leaving the grant economics intact. The filing also notes the reported direct holdings continue to include shares subject to unvested RSUs, indicating ongoing compensation-related equity exposure.

Key near-term items to track are the vesting schedule for outstanding RSUs and any future disclosures of sales or option exercises that would change the direct or indirect holdings materially.

AEHR Test Systems (AEHR) il direttore finanziario Chris Siu ha riferito una disposizione relativa a trattenute di 126 azioni ordinarie in data 10/02/2025 al prezzo di $32.25 per azione; la dichiarazione indica che queste azioni sono state trattenute per soddisfare gli obblighi di ritenuta fiscale al vesting delle unità azionarie soggette a restrizioni e non costituiscono una vendita da parte della persona che presenta il rapporto. Dopo la trattenuta, il rapporto mostra 75.409 azioni detenute beneficiariamente direttamente e 5.211 azioni detenute beneficiariamente indirettamente da un trust, con il totale diretto riportato che include azioni soggette a restrizioni non vestite delle unità azionarie soggette a restrizioni.

AEHR Test Systems (AEHR) el director financiero Chris Siu reportó una disposición relacionada con retención de 126 acciones comunes en fecha 10/02/2025 a un precio de $32.25 por acción; el escrito indica que estas acciones fueron retenidas para satisfacer las obligaciones de retención de impuestos al vesting de las unidades de acciones restringidas y no representan una venta por parte de la persona que presenta el informe. Después de la retención, el informe muestra 75,409 acciones beneficiosamente poseídas directamente y 5,211 acciones poseídas indirectamente por un fideicomiso, con el total directo informado que incluye las acciones sujetas a unidades de acciones restringidas no vestidas.

AEHR Test Systems (AEHR)의 최고재무책임자 크리스 시우는 126주 일반주를 예치 관련 처분을 보고했다. 날짜는 2025-10-02이고 주당 가격은 $32.25이다; 제출 문서에는 이 주식이 가상 실권 취득 시의 세금 원천징수 의무를 충족하기 위해 보류되었으며 보고자에 의한 매도를 나타내지 않는다고 명시되어 있다. 원천징수 후 보고서는 직접적으로 유익하게 보유한 주식 75,409주와 신탁에 의해 간접적으로 보유된 5,211주를 보여주며, 보고된 직접 총계에는 vesting되지 않은 제한 주식 단위로 주식이 포함되어 있다.

AEHR Test Systems (AEHR) le directeur financier Chris Siu a signalé une cession liée à une retenue de 126 actions ordinaires le 10/02/2025 au prix de $32.25 par action ; le dépôt indique que ces actions ont été retenues pour satisfaire les obligations de retenue d'impôt lors de l'acquisition des droits sur les unités d'actions restreintes et ne constituent pas une vente par la personne déclarant. Après la retenue, le rapport indique 75 409 actions détenues directement et 5 211 actions détenues indirectement par une fiducie, le total direct rapporté incluant les actions soumises à des unités d'actions restreintes non vesties.

AEHR Test Systems (AEHR) Chief Financial Officer Chris Siu meldete eine durch Abzüge bedingte Veräußerung von 126 Stammaktien am 10/02/2025 zu einem Preis von $32.25 pro Aktie; das Filing gibt an, dass diese Aktien gehalten wurden, um Steuerrückstände bei der Vesting von Restricted Stock Units zu befriedigen, und keine Veräußerung durch den meldepflichtigen Personen darstellt. Nach dem Abzug zeigt der Bericht 75.409 Aktien, direkt beneffizial besessen sind, und 5.211 Aktien indirekt durch einen Treuhändervertrag beneffizial besitzen, wobei der direkte Gesamtbestand Aktien umfasst, die unvested Restricted Stock Units unterliegen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Siu Chris

(Last) (First) (Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CA 94539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
3. Date of Earliest Transaction (Month/Day/Year)
10/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/02/2025 F 126(1) D $32.25 75,409(2) D
Common Stock 5,211 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units. This does not represent a sale by the Reporting Person.
2. The amount reported includes shares subject to unvested restricted stock units.
Remarks:
/s/SIU CHRIS 10/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

783.79M
28.16M
5.31%
60.66%
18.86%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT